Multimodal contrast agent and use thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- CHONGQING MEDICAL UNIVERSITY
- Publication Date
- 2019-04-26
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of pharmaceutical preparations, and specifically discloses a multimodal contrast agent and its application. Background technique
[0002] As a new type of cancer treatment technology, photothermal therapy can kill cancer cells by converting light energy into heat energy to rapidly heat up local tissues, realize fixed-point elimination of malignant tumors, and avoid systemic side effects. It is considered to replace surgical resection. One of the most promising technologies for the treatment of cancer. However, since biological tissues lack endogenous substances with significant photothermal effects in the near-infrared region, the effective implementation of photothermal therapy requires the assistance of phototherapeutic agents with strong absorption in the near-infrared region (700-1100nm). Generally speaking, phototherapeutic preparations (photothermal conversion materials) are required to have high phot...